Pfizer is pushing ahead with trials for a once-a-day weight loss pill as drug makers race to develop obesity treatments that are easier ... being developed by Pfizer but the company said its ...

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...